Mitochondrial Alterations in Alzheimer's Disease: Insight from the 5xFAD Mouse Model

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Mitochondrial dysfunction is implicated in Alzheimer's disease (AD) pathogenesis.
• The interplay between mitochondrial dynamics and proteinopathies in AD requires further elucidation.

Purpose of the Study:

• To investigate the role of mitochondrial dynamics and function in the hippocampus and peripheral blood mononuclear cells (PBMCs) of 5xFAD transgenic mice, an AD model.
• To assess changes in mitochondrial fusion and fission proteins, morphology, and function over time in AD mice.

Main Methods:

• Western blot analysis of mitochondrial proteins (OPA1, MFN2, DRP1, pDRP1, VDAC, TOM20, PINK1) in hippocampal tissue and PBMCs.
• Ultrastructural analysis of hippocampal mitochondria and mitochondria-associated ER.
• Flow cytometry to measure mitochondrial membrane potential, mass, and superoxide production in PBMCs.

Main Results:

• Reduced OPA1 and MFN2, increased DRP1 and pDRP1 in the hippocampus of 5xFAD mice.
• Decreased MFN2 in PBMCs of 5xFAD mice, indicating systemic alterations.
• Altered mitochondrial morphology, increased distance of mitochondria-ER contacts, decreased membrane potential and mass, and increased superoxide production in 5xFAD mice.
• Altered levels of VDAC, TOM20, and PINK1 in both central and peripheral tissues.

Conclusions:

• Mitochondrial dysfunction and altered dynamics are early events in AD development in 5xFAD mice.
• These mitochondrial abnormalities manifest systemically, affecting both brain and peripheral tissues.
• Targeting mitochondrial dynamics and function may offer therapeutic strategies for mitigating AD progression.